Intranasal dexmedetomidine in healthy beagles: An echocardiographic and pharmacokinetic/pharmacodynamic study
- 1 September 2019
- journal article
- research article
- Published by Elsevier in The Veterinary Journal
- Vol. 251, 105346
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Evaluation of intranasal delivery route of drug administration for brain targetingBrain Research Bulletin, 2018
- Mechanism of intranasal drug delivery directly to the brainLife Sciences, 2018
- A preliminary trial of the sedation induced by intranasal administration of midazolam alone or in combination with dexmedetomidine and reversal by atipamezole for a short-term immobilization in pigeonsVeterinary Anaesthesia and Analgesia, 2015
- Alpha-2 Adrenergic Receptor Agonists: A Review of Current Clinical ApplicationsAnesthesia Progress, 2015
- Intranasal Medications in Pediatric Emergency MedicinePediatric Emergency Care, 2014
- Intranasal drug delivery: An efficient and non-invasive route for systemic administrationPharmacology & Therapeutics, 2012
- Bioavailability of a novel midazolam gel after intranasal administration in dogsAmerican Journal of Veterinary Research, 2012
- Bioavailability of dexmedetomidine after intranasal administrationEuropean Journal of Clinical Pharmacology, 2011
- The effects of increasing doses of MK‐467, a peripheral alpha2‐adrenergic receptor antagonist, on the cardiopulmonary effects of intravenous dexmedetomidine in conscious dogsJournal of Veterinary Pharmacology and Therapeutics, 2010
- Intranasal delivery to the central nervous system: Mechanisms and experimental considerationsJournal of Pharmaceutical Sciences, 2010